PRMT5 and cancer: These data suggest that high PRMT5 activity leads to inactivation of p53 in certain genetic and phenotypic contexts, indicating that PRMT5 inhibition could lead to activation of p53 activity and its transcriptional programs in some p53 wild-type cancers.